Hormones including glucocorticoids (stress hormones) are well known for their effects on animal 16 behavior and life history traits, and this understanding has come through both correlative and 17 manipulative studies. While the latter offers a higher level of control (and ability to assign causality), 18 there are important methodological concerns that are often not considered when manipulating 19 hormones, including glucocorticoids, in wild animals. In this study, we examined how experimental 20 elevations of cortisol concentrations in wild North American red squirrels (Tamiasciurus hudsonicus) 21 affected their hypothalamic-pituitary-adrenal (HPA) axis reactivity, and life history traits including body 22 33 34
mass, litter survival, and adult survival. The effects of exogenous cortisol on plasma cortisol 23 concentrations depended on the time between treatment consumption and blood sampling. In the first 24 nine hours after consumption of exogenous cortisol, individuals had significantly higher true baseline 25 plasma cortisol concentrations, but adrenal gland function was impaired. Approximately 24 hours after 26 consumption of exogenous cortisol, individuals had much lower plasma cortisol concentrations than 27 controls, but adrenal function was restored. Corticosteroid binding globulin (CBG) concentrations were 28 also significantly reduced in squirrels treated with cortisol. Despite these profound shifts in the 29 functionality of the neuroendocrine stress axis, fitness proxies including squirrel body mass, offspring 30 survival, and adult survival were unaffected by experimental increases in cortisol concentrations. Our 31 results highlight that even short-term experimental increases in glucocorticoids can affect adrenal gland 32 functioning and CBG concentrations, but may have no side-effects on proxies of fitness.
Introduction

37
Associations between glucocorticoids (stress hormones) and life history or behavioral traits are 38 being increasingly studied, due to their role as a mechanistic link between the genome and the 39 environment, and to uncover general relationships between hormones and fitness (Breuner et al., 2008; 40 Dantzer et al., 2016) . Glucocorticoids (hereafter GCs), in particular, are receiving heightened focus, 41 because of the widespread relevance of the stress response mediated by the hypothalamic-pituitary-42 adrenal (HPA) axis (Sapolsky et al., 2000) . This includes documented effects of GCs on behavior and other 43 traits (e.g. DeNardo and Sinervo, 1994; Ebensperger et al., 2011) . Correlational studies have helped 44 advance our understanding of the relationships between GCs and phenotypic traits, but establishing the 45 causality of such relationships requires experimental manipulation (e.g. artificially elevating GCs). In 46 laboratory settings, hormone manipulations are logistically feasible (e.g. Karatsoreos et al., 2010; Lussier 47 et al., 2009 ), but experimental studies conducted in wild populations are likely to provide better insights 48 into the ecologically relevant effects of GCs on life history variation. 49 Hormone manipulations in wild animals are more challenging than in the laboratory, but several 50 methods have been developed (see Sopinka et al., 2015) . That said, exogenous GCs may have unintended 51 physiological side effects, which may influence or skew interpretation of the results obtained from 52 manipulative studies. Although detailed studies about the potential complications of manipulating 53 hormones in wild animals have not been performed, these issues were highlighted 10 years ago (Fusani, 54 2008). One potential problem with hormone manipulations is related to the fact that the endocrine 55 system is a homeostatic system that is controlled by negative feedback mechanisms, and tends to 56 compensate for disruption. Therefore, if animals are treated with a hormone, the endogenous 57 production of the hormone may be reduced after a few days, and longer treatment duration may lead 58 4 to the regression of the endocrine gland, and have important consequences for endocrine homeostasis 59 (Fusani, 2008) . Such effects are well documented in humans, as both cortisol and synthetic GCs (which 60 may be more potent, see Meikle and Tyler, 1977) , are used to treat a range of ailments (Arabi et al., 61 2010; Kirwan et al., 2007) . Such treatments may lead to side-effects, including suppression of the HPA 62 axis and reduced adrenal function (Broide et al., 1995; Feiwel et al., 1969; Jacobs et al., 1983) . Although 63 such side-effects are usually temporary (Morris and Jorgensen, 1971; Streck and Lockwood, 1979) , in 64 extreme cases, patients may develop more severe and long term conditions such as Cushing's syndrome 65 (symptoms include obesity, poor wound healing, and hypertension, see Axelrod, 1976) . In other cases, 66 GC therapy may cause secondary adrenal insufficiency and lead to Addison's disease (Arlt and Allolio, 67 2003). If GC manipulations affect the adrenal glands, endogenous production of GCs, and endocrine 68 homeostasis, this may lead to unintended consequences in wild animals. This could jeopardize the value 69 of performing such studies, as they could adversely influence survival and reproduction. Indeed, some 70 studies indicate that elevations in stress hormones reduce estimates of fitness (Bonier et al., 2009; 71 Breuner et al., 2008; Wingfield et al., 1998) , but it is unclear if this is due to an unintended complication 72 from the manipulation rather than a natural consequence of increased stress hormones. 73 We examined how exogenous cortisol affected the HPA axis and life history traits of North 74 American red squirrels (Tamiasciurius hudsonicus). We expected that exogenous cortisol would increase 75 plasma cortisol concentrations, but that, as may be the case in humans receiving GC therapy, HPA axis 76 responsiveness would decrease. We expected that exogenous cortisol might lead to increased body mass 77 in squirrels (Axelrod, 1976), but did not expect our treatment dosages to be sufficiently high to cause 78 anorexia through sustained adrenal impairment (Arlt and Allolio, 2003) . As we aimed to keep 79 5 physiological stress within a 'normal' range for this species, we did not expect to see negative effects of 80 our treatments on body mass or adult or litter survival. 81
Materials and Methods
82
2.1 Study population 83 We studied a natural population of red squirrels in the Yukon, Canada (61°N, 138°W) that has 84 been monitored since 1987 (Boutin et al., 2006; McAdam et al., 2007) . All squirrels in this population are 85 individually identified by a unique ear tag in each ear, as well as a unique color combination of colored 86 wires attached to each ear tag which allow researchers to identify individuals from a distance. Squirrels 87 were live-trapped (Tomahawk Live Trap Co., WI, USA), during which they were weighed using a Pesola 88 spring balance, and fecal samples were collected from underneath traps, placed on ice, and stored at -89 20 °C upon return to the field station (Dantzer et al., 2010) . Female and male reproductive condition was 90 assessed through abdominal palpation (see McAdam et al., 2007) . 91 
GC manipulations 92
In 2015, and 2016, squirrels were randomly allocated to either control (8 g all natural peanut 93 butter, 2 g wheat germ, no cortisol) or cortisol treatments (8 g peanut butter, 2 g wheat germ with 6, 8, 94 or 12 mg of cortisol [H4001, Sigma Aldrich, USA]). Dosages of 0, 6, and 12 mg cortisol were selected 95 following Dantzer et al. (2013) , who based their selected dosages on previous studies in similar sized 96 rodents that showed that a dose of 12 mg/day of cortisol induces chronic mild stress (Casolinia et al., 97 1997; Catalani et al., 2002; Mateo, 2008) . We also added an intermediate dose of 8 mg cortisol/day. 98 Cortisol was provided to squirrels as 10 g dosages placed in buckets hung from trees in squirrel territories 99 (for details, see Dantzer et al., 2013) . To ensure that target squirrels (identifiable through ear tags/radio-100 6 collars) were consuming the treatments, camera traps (Reconyx PC900 HyperFire Professional Covert IR) 101 were placed by the buckets of 31 squirrels for 5 days. Out of 155 d of camera trapping, conspecific 102 pilferage was only observed ten times, and there was one case of heterospecific pilferage by a grey jay 103 (Perisoreus canadensis). Consumption of each treatment was estimated daily by checking buckets for 104 any leftovers and estimating these as a percentage. Squirrels consumed on average 91.9% of their total 105 peanut butter treatments (median = 100%, SD = 12.13%, range = 43-100%). 106 
Effects of exogenous cortisol on fecal glucocorticoid metabolites (FGM) 107
To evaluate the effects of cortisol treatments on FGM, fecal samples were collected in 2015 and 108 2016 from male and female squirrels fed with 0, 6, 8, and 12 mg cortisol/day (Table 1) . Glucocorticoid 109 metabolites from fecal samples were extracted and assayed as previously validated and described 110 (Dantzer et al., 2011 (Dantzer et al., , 2010 using a 5α-pregnane-3β,11β,21-triol-20-one enzyme immunoassay (Touma   111   et al., 2003) . Intra-and inter-assay CVs for pools diluted 1:250 (n = 13 plates) were 7.4% and 15.4%. For 112 pools diluted 1:500 (n = 13 plates) this was 7.5% and 17.9%. Pools diluted 1:100 (n = 9 plates) had intra 113 and inter-assay CVs of 10.0% and 17.9%, and for pools diluted at 1:700 (n = 9 plates) this was 6.4% and 114 18.9%. Samples from control (n = 135) or cortisol (n = 237) treated squirrels included those collected 115 before, during, and after treatment. Non-breeding male squirrels were fed cortisol (8 mg/day) or control treatments for one (n = 40) 118 or two weeks (n = 26). Eighteen squirrels were included in both spring/summer (mid-April to mid-July) 119 and autumn 2016 (mid-September to early October, with treatments switched between periods, with 120 the exception of two squirrels fed GCs twice and one squirrel fed control treatments twice, due to human 121 7 error). The time that squirrels consumed their treatments was estimated by checking buckets at intervals 122 between 25 minutes and a few hours (shown as hours:min, mean = 1:53 hrs, SD = 1:12 hrs). Squirrels 123 were either blood sampled the same day as confirming they consumed their last treatment (n = 36, mean 124 = 3:30 hrs, range = 0:57-8:55 hrs, referred to as 'same day bleeds' hereafter) or the next day (n = 30, 125 mean = 22:46 hrs, range = 14:57-30:55 hrs, referred to as 'next day bleeds' hereafter. Note that for 19 126 next day bleed squirrels, the time of treatment consumption was not recorded). Blood samples obtained 127 within 3 min of squirrels entering a trap (n = 54) are referred to as true baseline samples (Romero et al. 128 2005). If the first blood sample was obtained >3 min after squirrels went into traps (n = 12), this is 129 referred to as nominal baseline samples. 130 Blood samples were obtained from the nailbed and collected into heparinized capillary tubes. To 131 determine how exogenous cortisol affected the HPA axis, we used two different methods. We either 1) 132 subjected squirrels to dexamethasone and adrenocorticotropic hormone challenges (n = 32, hereafter 133 referred to as DEX/ACTH challenges) following previously described protocols (Boonstra and McColl, 134 2000), with modified concentrations of dexamethasone (3.2 mg/kg, hereafter, DEX) and 135 adrenocorticotropic hormone (4 IU/kg, hereafter ACTH), or 2) bled them at intervals of 0-3 min (samples 136 shown as same day/next day: squirrel n = 23/11), 3-6 min (n = 14/6), 6-12 min (n = 15/7), and 18-22 min 137 (n = 16/11, hereafter referred to as timed bleeds) to assess the response to handling stress. 138 Total plasma cortisol concentrations were assayed using an ImmuChem coated tube cortisol 139 radio-immunoassay (MP Biomedicals, New York, USA) following the manufacturer's instructions, with 140 the exception that, due to small sample volumes, plasma and tracer volumes of 12.5 µL and 500 µL were 141 used. Linearity was tested by pooling several samples and serially diluting these from 1 (neat) to 1:64. 142 8 Results were plotted, visually inspected, and evaluated with linear regression (R 2 adj = 0.991, p < 0.001). 143 According to the manufacturer, the assay detection limit is 1.7 ng/ml, and samples that read below this 144 value (n = 8) were set at 1.7 ng/ml. Most samples were run in duplicate, but because of small plasma 145 volumes only one estimate was obtained for 33.9% of samples. Average standard and sample intra-assay 146 CVs were 7.9% (n = 4 assays). Inter-assay CVs for the five standards provided (10, 30, 100, 300 and 1000 147 ng/ml cortisol) were 11.1%, 15.4%, 8.8%, 4.0% and 7.7%. 148 Corticosteroid binding capacity was measured in plasma stripped of endogenous steroids using 149 dextran-coated charcoal (DCC) and diluted to a final dilution of 1/50 in phosphate buffered saline with 150 0.1% gelatin (PBS). Three tubes (final volume of 150 µL) were prepared for each sample: two containing 151 160 nM cortisol (10% 1,2,6,7-3 H-cortisol, Perkin Elmer, Waltham, MA, and 90% non-labeled cortisol, C-152 106, Sigma-Aldrich) to measure total binding, and one containing an additional 4 µM non-labeled cortisol 153 to measure nonspecific binding (primarily by albumin). After incubating tubes overnight, 300 µL of ice-154 cold DCC was added and left for 15 minutes to strip free cortisol from the plasma mixture. The tubes 155 were then centrifuged at 2000 x g at 4 °C for 12 minutes. The supernatant (containing bound cortisol) 156 was decanted into scintillation vials, to which 4 mL of scintillation fluid (Emulsifier-Safe cocktail, Cat. No. 157 6013389, Perkin Elmer, Groningen, Netherlands) was added. Vials were counted in a scintillation counter. 158 Specific binding by CBG was calculated by subtracting nonspecific binding counts from total binding 159 counts. Specific binding scintillation counts were converted to nM binding by measuring the total counts 160 in the 150 µL of the 160 nM solution and adjusting for the plasma dilution. Some CBG-bound hormone 161 is lost to the DCC during the 15 minute DCC exposure. Using pooled plasma exposed to DCC for 5-20 162 minutes, we calculated the rate of loss of CBG-bound cortisol (data not shown). From this, we calculated 163 that the 15 minute DCC exposure resulted in the loss of 28.5% of CBG-bound hormone, and all our 164 9 specific binding measurements were corrected accordingly. To calculate the percent free cortisol, we 165 estimated free cortisol concentrations (i.e. not bound by CBG) using the total cortisol concentration, the 166 equilibrium dissociation constant for red squirrels of 61.1 nM (Delehanty et al., 2015) , and the equation 167 in Barsano and Baumann (1989) . As plasma volumes were limited, only 58 samples could be assayed for 168 both CBG/percent free cortisol and total cortisol. after treatments started, mean = 12 days, SD = 7). Because data on litter survival in 2015 and 2016 were 174 limited, we also included data on litter fate collected in 2012 from squirrels fed the same dosages (0, 6, 175 12 mg cortisol/day) for similar periods of time (see Dantzer et al., 2013) . When females gave birth, their 176 nests were located within a few days of parturition (first nest entry) and again when pups were ~25 d 177 old (second nest entry) following McAdam et al. (2007) . We examined how our treatments affected 178 whether females treated during pregnancy (control n = 24, 6 mg cortisol/day n = 9, 8 mg cortisol/day n 179 = 16, 12 mg cortisol/day n = 22) or lactation (control n = 8, 12 mg cortisol/day n = 9) lost their litters 180 before the first nest entry or between the first and second nest entry, as determined by abdominal 181 palpation. Females treated during pregnancy were treated from the estimated last third of pregnancy 182 (based on abdominal palpation), until five days post parturition (treatment duration range = 8 -25 days, 183 mean = 18, SD = 4). Females treated during lactation were treated for 10 days, from days 5 to 15 post 184 parturition, although due to human error and field conditions, one female was treated for 8, and another 185 10 for 11 days (range = 8 -11 days, mean = 10, SD = 0.6). Adult squirrel survival was monitored through 186 regular live trapping and behavioral observations (McAdam et al., 2007) . Survival data were only 187 available from squirrels studied in 2015 (n = 50, including 41 females and nine males). These squirrels 188 were fed either control treatments (n = 25, 10 -26 days, mean = 19, SD = 7) or 12 mg cortisol/day (n = 189 25, 8 -35 days, mean = 20, SD = 7). Although we did not know the ages of all squirrels, there was no age 190 bias between squirrels fed control (eight known ages, mean = 4.05, SD= 1.05 years) and those fed cortisol 191 (nine known ages, mean = 3.97, SD = 0.87 years, t13.8= 0.18, p = 0.86). We estimated survival until exactly 192 1 year after the treatments were stopped. comparisons between groups, we used the 'glht' function in R package 'multcomp' (Hothorn et al., 2017). 199 Model residuals were plotted to check for conformity with homogeneity of variance and normality (Zuur 200 et al., 2010) . Where necessary, data were ln transformed. Regression lines were visualized using R 201 package 'visreg' (v 2.2.2, Breheny and Burchett, 2016) . 202 We tested effects of treatments on FGM concentrations using LMMs, analyzing female and male 203 data separately due to differences in reproductive states. Models for females included dose (0, 6, 8, 12 204 mg of cortisol/day), reproductive state (non-breeding, pregnant, lactating), Julian date, and whether the 205 squirrel was treated on the sampling day (yes/no) as fixed effects, with an interaction term for dose and 206 11 treatment (yes/no). Models for males included the same variables (but only doses of 0 and 8 mg) except 207 reproductive state (all were non-breeding). To test for lasting effects of treatments on FGM, we analyzed 208 samples collected between 1-21 d after treatments stopped. We included an interaction between dose 209 and days after treatments ended in an LMM, as above. 210 Regarding blood sample collection, there was no daytime sampling bias between cortisol 211 treated (between 9:41 and 18:07, mean = 13:23) and control squirrels (between 9:33 and 17:31, mean 212 = 13:50, t-test, t42.15= 1.14, p = 0.26), and no effect of sampling time on plasma cortisol (linear regression, 213 b = 0.008, t0.07 = 0.11, p = 0.91), indicating that there were no effects of circadian patterns in our dataset. 214 Squirrels were either subjected to DEX/ACTH challenges, or squirrels were subjected to timed 215 bleeds (and blood samples were collected between 2 and 28 minutes after trap doors closed). LMMs 216 were run separately for DEX/ACTH challenges and timed bleeds. Models included fixed effects for 217 treatment and bleed time. For DEX/ACTH challenges bleed times included the categorical variables 'true 218 baseline', 'nominal baseline', '60 minutes after DEX injection' (hereafter; DEX), '30 minutes after ACTH 219 injection' (hereafter; ACTH30), and '60 minutes after ACTH injection' (hereafter; ACTH60); for timed 220 bleeds, bleed times were expressed as minutes since the squirrel was trapped (continuous variable, 221 standardized following Schielzeth, 2010). Two plasma samples with very low binding (<10%) were 222 excluded from the analysis. Some models included squirrels treated for either 1 or 2 weeks, and some 223 included squirrels that were treated in both spring and autumn. Where this was the case, treatment 224 duration (1/2 weeks) and whether or not squirrels had been treated before (yes/no) was included in the 225 models. However, these variables were not significant in any of the models, and are not discussed further. To estimate the total plasma cortisol in a 24 h period, true baseline cortisol was plotted against 238 the time since treatment was consumed. Regression line equations were used to calculate the area 239 under these lines for both control and cortisol treated squirrels, using the 'trapzfun' command in package 240 'pracma' (Borchers, 2018) , and areas under the curve were compared with χ 2 tests. 241 Data on body mass were subset into those collected in spring (females fed 0 or 12 mg cortisol/day) 242 and autumn (males fed 0 or 8 mg cortisol/day). Body masses were compared using LMMs including a 243 two-way interaction between treatment, and time (before/during treatment). To assess differences 244 between litter survival (lost/not lost), and adult survival (yes/no) GLMs were applied using binomial Overall, squirrels fed cortisol treatments (6, 8, 12 mg/day) had significantly higher FGM 252 concentrations than when they were not being fed (F3,263.8= 11.5, p < 0.001, Fig. 1 ), but the magnitude 253 of increase depended on the dosage. Squirrels fed plain peanut butter with no cortisol did not have 254 higher FGM concentrations when they were being fed their treatments compared to when they were 255 not being fed their treatments (females: b = -0.03, SE = 0.15, z = 0.22, p = 1.0; males: b =0.14, SE= 0.36, 256 z = 0.41, p = 0.96). FGM concentrations in squirrels fed 6, 8, or 12 mg cortisol/day in both females and 257 males were significantly higher compared when they were being fed compared to when they were not 258 being fed (6 mg: b = 0.78, SE = 0.28, z = 2.8, p = 0.032; 8 mg: females: b = 0.79, SE = 0.21, z = 3.9, p < 259 0.001; males: b =1.37, SE= 0.49, z = 2.82, p = 0.013; 12 mg: b = 1.39, SE = 0.17, z = 8.0, p < 0.001). 260 Concentrations of FGM during treatment in female squirrels treated with 12 mg vs 8 mg (b = 0.39, SE = 261 0.28, z = 1.4, p = 0.63), 6 mg vs 8 mg (b = 0.36, SE = 0.36, z = 1.0, p = 0.88), and 6 mg vs 12 mg cortisol/day 262 (b = 0.74, SE = 0.35, z = 2.1, p = 0.18) were not significantly different. Julian date did not affect FGM 263 concentrations in females (F1,284.9 = 3.44, p = 0.06) or males (F1,15.2 = 0.73, p = 0.41). Reproductive 264 condition did not affect FGM in this dataset, possibly because of limited sample numbers on some 265 reproductive states (see Table 1 , F2,105.0 = 1.37, p = 0.26). 266 There was little evidence that the GC treatments had a lasting influence on FGM concentrations 267 in squirrels. FGM concentrations in control females (b = -0.03, SE = 0.03, t = -1.16, DF = 53.9, p = 0.25) 268 and males (b = -0.25, SE = 0.16, t = -1.61, DF = 8.4, p = 0.14) did not change in the 1-21 days after 269 treatments stopped, nor did FGM concentrations from females (b = -0.01, SE = 0.04, t = 1.48, DF = 53.3, 270 14 p = 0.14) and males (b = 0.19, SE = 0.16, t = 1.2, DF = 8.4, p = 0.26) treated with 8 mg cortisol/day (although 271 sample sizes from males were small). FGM concentrations in females treated with 6 mg cortisol/day also 272 did not significantly change in the 1-21 days after treatments stopped (b = -0.01, SE = 0.06, t = -0.21, DF 273 = 53.9, p = 0.14), but FGM concentrations in females treated with 12 mg of cortisol/day significantly 274 increased after treatments stopped (b = 0.08, SE = 0.04, t = 2.31, DF = 49.8, p = 0.02, Fig. 2) . Fig. 3B ). Plasma cortisol 299 concentrations after the DEX injection were also lower in cortisol treated squirrels (56.5±34.6 ng/ml) 300 than controls (239.8±24.8 ng/ml, a 76.4% difference, b = -183.3, SE = 53.7, z = -3.4, p = 0.006). Thirty 301 minutes after the ACTH injection, cortisol treated squirrels (mean = 97.9±19.9 ng/ml) had plasma cortisol 302 concentrations that were on average 80.4% lower than in control squirrels (mean = 498.8±34.6 ng/ml, b 303 = 398.1, SE = 57.5, z = -6.9, p < 0.001). This difference remained 60 min after the ACTH injection (cortisol 304 mean = 101.7±11.4 ng/ml, control mean = 469.0±89.2 ng/ml, a difference of 78.3%, b = -368.2, SE = 56.8, 305 z = -6.5, p < 0.001, Fig. 3B ). 306 In squirrels sampled the day after receiving their last treatment, control squirrels (b = -211.9, 307 SE = 53.7, z = -3.9, p < 0.001), but not cortisol treated squirrels (b = 9.6, SE = 49.4, z = 0.2, p = 1.0), had 308 significantly lower plasma cortisol concentrations 60 minutes after DEX injections compared to nominal 309 baselines. Thirty minutes after the ACTH injection (ACTH30), control squirrels (b = 257.3, SE = 45.6, z = 310 5.6, p < 0.001), had significantly higher plasma cortisol concentrations than 60 minutes after DEX 311 injections. In cortisol treated squirrels, plasma cortisol concentrations were higher at 30 minutes after 312 16 ACTH injection (ACTH30) than 60 minutes after DEX injection, but this was not significant (b = 42.6, SE = 313 44.7, z = 0.95, p = 0.95, Fig. 3B ). Fig. 4A ). 325 Plasma cortisol concentrations were generally lower in cortisol treated squirrels that were bled 326 the day after consuming their last treatment than in control squirrels (b = -1.8, SE = 0.81, t = -2.2, DF = 327 8.4, p = 0.057). Handling time generally increased plasma cortisol concentrations (b = 0.42, SE = 0.20, t = 328 2.1, DF = 19.2, p = 0.048), and this was not affected by treatment (b = 0.40, SE = 0.1.4, DF= 18.7, p = 0.16). 329 The time since squirrels consumed their last treatments significantly affected true baseline 330 plasma cortisol in cortisol treated squirrels (b = -0.27, SE = 0.04, t = -6.1, p < 0.001) but not controls (b = 331 -0.02, SE = 0.03, t = -0.58, p = 0.57, Fig. 5 ). Plasma cortisol increased after squirrels consumed their 332 cortisol treatments, but declined with time post-consumption, until, ~20 hours post-consumption, 333 plasma cortisol was much lower in cortisol fed than in control squirrels (Fig. 5) . Overall, squirrels fed 334 cortisol experienced significantly higher plasma cortisol (total area = 7907.4 units) than controls (total 335 area = 4110.8 units, χ=614.4, DF = 1, p < 0.001, Fig. 5 ) in a 24 h period. 336 
Effects of treatments on CBG
337
Cortisol treatment significantly lowered CBG concentrations in squirrels DEX/ACTH challenged 338 on the same day as consuming their last treatments (F1,5.0 = 51.0, p < 0.001, Fig. 6A ). Cortisol treatment 339 also significantly lowered CBG concentrations in squirrels DEX/ACTH challenged the day after consuming 340 their last treatment (F1,12.9 = 29.3, p < 0.001). Consequently, cortisol treatment significantly increased the 341 proportion of free cortisol in plasma in squirrels DEX/ACTH challenged on the same day (F1,5.0 = 7.6, p = 342 0.04) and the day after consuming their last treatments (F1,12.1 = 15.3, p = 0.002, Fig. 6B ). Treatment did 343 not affect plasma CBG concentrations at different sample times (nominal baseline, DEX, ACTH30, 344 ACTH60) in squirrels sampled the day after consuming their last treatment (F3,6.2 = 1.0, p = 0.46), nor 345 percent free cortisol (F3,12.3 = 0.5, p = 0.71). Cortisol treatment also lowered CBG concentrations in 346 squirrels subjected to timed bleeds (F1,7.0 = 24.5, p = 0.002, Fig. 6A ), and increased percent free cortisol 347 (F7.0 = 2.3, p = 0.17). The effect of treatment on plasma CBG concentrations (F7.0 = 1.3, p = 0.30) and 348 percent free cortisol (F1,7.0 = 1.9, p = 0.21) was not different between squirrels sampled the same day or 349 the day after last treatment. 350 
Effects of treatments on body mass 351
There was no effect of the interaction between treatment (control or 12 mg cortisol/day) and 352 time of sampling (during treatment yes/no) on masses of control females (n = 24 before, n = 23 during 353 treatment records) and females fed 12 mg cortisol/day (n = 30 before, n = 31 during treatment records, 354 b= -3.9, SE = 4.9, t87.9 = -0.79, p = 0.43). There was also no effect of the interaction between treatment 355 and time of sampling on masses of males fed 8 mg cortisol/day (n = 17 before, n = 11 during treatment 356 18 records) and males fed control treatments (n = 20 before, n = 17 during treatment records, b = 6.9, SE = 357 4.8, t29.3 = 1.4, p = 0.16). 358 
Effects of treatments on litter survival 359
There was no significant difference in litter survival rates before the first nest entry between 360 females treated with cortisol during pregnancy (14/47 lost) and controls (7/24 lost; z0.55 = 0.13, p = 0.89). 361 When dosages (0, 6, 8, 12 mg/day) were analyzed separately, there also was no evidence of any dosage 362 significantly affecting litter survival prior to the first nest entry (6 mg: z0.81 = -1.4, p = 0.17: 8 mg; z0.78 = 363 0.74, p = 0.46; 12 mg: z0.68 = 0.50, p = 0.62). 364 There were also no significant differences in litter survival between the first and second nest 365 entry between females treated with cortisol during pregnancy (17/47) and controls (4/24: z0.55 = -0.05, p 366 = 0.96). There was no evidence of dosages of 6, 8, or 12 mg/day significantly affecting litter survival 367 between the first and second nest entries (6 mg: z0.81 = -1.38, p = 0.17; 8 mg: z0.73 = 0.29, p = 0.77, 12 mg: 368 z0.68 = 0.50, p = 0.62). 369 For females treated during lactation (n = 17), there was no significant difference in litter survival 370 between the first and second nest entry, with 1/8 control females losing their litter and 3/9 cortisol fed 371 (12 mg/day) females losing their litter (z1.3 = -0.98, p = 0.33). 372 
Effects of treatments on adult survival 373
There was no difference in survival to one year following cessation of the treatments between 374 controls (18/25 survived to one year) and those fed cortisol (14/25 survived to one year; z0.6 = -1.13, p = 375 0.26). There was no difference in survival between males (7/9 survived to one year), and females (25/41 376 survived to one year, z0.9 = 0.89, p = 0.37). 377 378
Discussion
379
Our results on cortisol manipulations in wild red squirrels, spanning a range of dosages, life 380 history stages, and including both sexes, provide important information regarding the response of wild 381 animals to such hormone manipulation. Squirrels treated with cortisol had higher FGM concentrations 382 and plasma cortisol concentrations over a 24 h period. However, our results highlight that exogenous 383 GCs can cause the adrenals to stop responding to handling stress or pharmaceutical (DEX/ACTH) 384 challenges, although these effects were short-lived and did not affect fitness proxies, including body 385 mass, and offspring or adult survival. 386 Concentrations of CBG were significantly reduced in squirrels treated with cortisol for one or 387 two weeks, suggesting that chronically elevated GCs reduce CBG concentrations. This reduction in CBG 388 is likely to result in a higher bioavailability of plasma cortisol (Breuner et al., 2013) . Studies in rats have 389 shown that administration of exogenous GCs can inhibit the rate of CBG production and secretion in the 390 liver (Feldman et al., 1979) , and one study found that, 24 hours after acute stress, CBG concentrations 391 were reduced in rats (Fleshner et al., 1995) . Chronic stress has also been shown to lead to reduced CBG 392 concentrations in most species studied to date (Armario et al., 1994; Breuner et al., 2013) . A previous 393 study found that CBG concentrations in red squirrel plasma (which were initially high) started to decrease 394 as quickly as four hours after the start of DEX/ACTH challenges, suggesting that although high 395 concentrations of CBG may buffer squirrels from the effects of high concentrations of free cortisol 396 caused by acute stressors, these concentrations decline rapidly when the duration of the stressor is 397 longer than a few hours (Boonstra and McColl, 2000) . However, this does not seem to carry any 398 noticeable cost as there were no changes in body mass or litter and adult survival in response to our 399 treatments. 400 20 Previous reviews have emphasized the importance of maintaining hormone concentrations 401 within a physiological range when performing hormone manipulations (Crossin et al., 2016; Fusani, 2008; 402 Zera, 2007) . Studies in mammals have shown that acute experimental challenges can cause increases in 403 plasma cortisol that are comparable to those achieved by our treatments. For example, in both 404 laboratory rats and wild animals, physical restraint, open field trials, and maze tests may cause >10 fold 405 increases in plasma glucocorticoid concentrations (Cockrem, 2013) . In control squirrels, plasma cortisol 406 concentrations increased up to 10.4 fold from true baseline concentrations in timed bleeds, indicating 407 that plasma cortisol could increase by this much without chemical stimulation. In this study, the highest 408 recorded true baseline plasma cortisol concentration in cortisol treated squirrels was approximately 409 seven times higher than the average control true baseline plasma cortisol concentration. This suggests 410 that the increase in plasma cortisol caused by our 8 mg cortisol/day treatment is within the physiological 411 range for a squirrel. However, it is possible that the duration of elevated plasma cortisol caused by our 412 treatments is longer than that caused by natural stressors. Studies in rats show that plasma 413 glucocorticoids increase quickly in response to acute stress, but returns to baseline concentrations 414 within 2-5 hours after the stressor is removed (Marin et al., 2007; Mizoguchi et al., 2001) , but in cortisol 415 treated squirrels, plasma cortisol remained elevated, compared to control squirrels, for an estimated 17 416 hours post-treatment. 417 Our results highlight the importance of regularly provisioning individuals with treatments to 418 sustain increases in hormone concentrations. Although we did find that squirrels fed cortisol had 419 significantly higher concentrations of plasma cortisol over a 24 hr period than the controls, it was 420 important to provision individuals with the treatments every 24 hrs. This was because plasma cortisol in 421 cortisol treated squirrels did decrease to concentrations well below those of control squirrels >20 hrs 422 21 after consuming their treatments. When it is feasible, daily supplementation may be effective in 423 maintaining sustained elevations in hormone concentrations and provide an alternative to other 424 methods like implants that carry some disadvantages (Sopinka et al., 2015) . 425 Our results also highlight the potentially adverse consequences that may occur when ending 426 hormone manipulations in wild animals. When sampled less than a day after the end of cortisol 427 treatment, squirrels did not respond to handling stress or ACTH injection, and appeared to have impaired 428 adrenal function and lower CBG concentrations. Data collected from cortisol treated squirrels the day 429 after consuming their last treatment showed that plasma cortisol was very low compared to control 430 squirrels, suggesting exogenous GCs have been excreted but endogenous GCs were being produced at a 431 lower rate than in control animals. However, plasma cortisol did increase with handling stress, suggesting 432 some recovery of adrenal function within 24 hrs of stopping the treatments. Data on FGM collected 433 between 0-21 d after treatments were stopped suggest that in squirrels fed 6 or 8 mg cortisol/day there 434 were no longer-term treatment effects, although squirrels fed 12 mg/day showed increases in FGM in 435 the 21 d following the end of treatment. Our results suggest that the adrenal gland may need time to 436 recover from treatment, and endogenous cortisol production may not return to pre-treatment levels for 437 several days. 438 Hormone manipulations can provide powerful tools to study relationships between hormones 439 and life history traits, and in recent years methods have been developed to achieve this (Sopinka et al., Table 1 : Sample sizes used in this study. Period refers to when squirrels were treated. Preg: females 635 treated from the estimated last third of pregnancy until 5 days post parturition. Lac: females treated 636 from days 5 -15 post parturition. NB: males and females treated outside of the breeding season. 637 Treatment duration is shown as the range and mean ± SEM. Samples (n) refers to the number of fecal 638 samples. F refers to females, M refers to males, SD refers to standard deviation. 
